Accessibility Menu
 
Biophytis logo

Biophytis

(NASDAQ) BPTS

Current PriceN/A
Market CapN/A
Since IPO (2021)-100%
5 Year-100%
1 Year-87%
1 Month-10%

Biophytis Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$0.00

Net Income (TTM)

$34.66M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

BPTS News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Biophytis

Industry

Biotechnology

Employees

20

CEO

Stanislas Veillet, PhD

Headquarters

Paris, 75005, FR

BPTS Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

92%

Return on Capital

2%

Return on Assets

-1%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Short Interest

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$803.00K

Operating Income

$14.33M

EBITDA

$13.80M

Operating Cash Flow

$12.87M

Capital Expenditure

$220.00K

Free Cash Flow

$13.09M

Cash & ST Invst.

$5.57M

Total Debt

$8.27M

Biophytis Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2024YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

N/A

N/A

Market Cap/Employee

N/A

N/A

Employees

22

N/A

Net Income

$5.81M

+6.2%

EBITDA

$4.27M

+27.5%

Quarterly Fundamentals

Name
Q2 2024YOY CHG

Net Cash

$7.52M

-231.0%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

-100.0%

Long Term Debt

$818.00K

-79.4%

Short Term Debt

$8.89M

-12.0%

Return on Assets

-1.21%

N/A

Return on Invested Capital

1.94%

N/A

Free Cash Flow

$5.96K

-15.9%

Operating Cash Flow

$5.95K

-16.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
PTNPalatin Technologies, Inc.
$17.20-1.26%
EIGRQEiger BioPharmaceuticals, Inc.
$8.50+6.25%
NOVNNovan, Inc.
$0.09-24.84%
ARAVAravive, Inc.
$0.04-13.39%

Trending Stocks

Symbol / CompanyPricePrice Chg
CYCNCyclerion Therapeutics
$6.38+3.12%
INTCIntel
$48.03+0.09%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.23+0.04%
NKENike
$44.63-0.16%

Questions About BPTS

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.